Annual Accounts Payable
$42.11 M
-$1.16 M-2.68%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual accounts payable is $42.11 million, with the most recent change of -$1.16 million (-2.68%) on December 31, 2023.
- During the last 3 years, RARE annual accounts payable has risen by +$29.19 million (+225.88%).
- RARE annual accounts payable is now -2.68% below its all-time high of $43.27 million, reached on December 31, 2022.
Performance
RARE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$35.99 M
-$23.82 M-39.82%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly accounts payable is $35.99 million, with the most recent change of -$23.82 million (-39.82%) on September 30, 2024.
- Over the past year, RARE quarterly accounts payable has increased by +$2.63 million (+7.89%).
- RARE quarterly accounts payable is now -39.82% below its all-time high of $59.81 million, reached on June 30, 2024.
Performance
RARE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RARE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.7% | +7.9% |
| 3 y3 years | +225.9% | +131.1% |
| 5 y5 years | +243.1% | +167.4% |
RARE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.7% | +145.7% | -39.8% | +110.0% |
| 5 y | 5-year | -2.7% | +227.2% | -39.8% | +299.3% |
| alltime | all time | -2.7% | >+9999.0% | -39.8% | +2899.2% |
Ultragenyx Pharmaceutical Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $35.99 M(-39.8%) |
| Jun 2024 | - | $59.81 M(+46.0%) |
| Mar 2024 | - | $40.97 M(-2.7%) |
| Dec 2023 | $42.11 M(-2.7%) | $42.11 M(+26.3%) |
| Sep 2023 | - | $33.36 M(-20.8%) |
| Jun 2023 | - | $42.12 M(-28.6%) |
| Mar 2023 | - | $58.98 M(+36.3%) |
| Dec 2022 | $43.27 M(+152.5%) | $43.27 M(+83.9%) |
| Sep 2022 | - | $23.53 M(-31.2%) |
| Jun 2022 | - | $34.21 M(+44.5%) |
| Mar 2022 | - | $23.68 M(+38.2%) |
| Dec 2021 | $17.14 M(+32.6%) | $17.14 M(+10.0%) |
| Sep 2021 | - | $15.57 M(-28.5%) |
| Jun 2021 | - | $21.79 M(+38.4%) |
| Mar 2021 | - | $15.74 M(+21.8%) |
| Dec 2020 | $12.92 M(+0.4%) | $12.92 M(+19.1%) |
| Sep 2020 | - | $10.85 M(+20.4%) |
| Jun 2020 | - | $9.01 M(-37.4%) |
| Mar 2020 | - | $14.40 M(+11.9%) |
| Dec 2019 | $12.87 M(+4.9%) | $12.87 M(-4.4%) |
| Sep 2019 | - | $13.46 M(+54.0%) |
| Jun 2019 | - | $8.74 M(-31.0%) |
| Mar 2019 | - | $12.66 M(+3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $12.28 M(+38.1%) | $12.28 M(+49.7%) |
| Sep 2018 | - | $8.20 M(-20.5%) |
| Jun 2018 | - | $10.31 M(+36.3%) |
| Mar 2018 | - | $7.57 M(-14.8%) |
| Dec 2017 | $8.89 M(+65.7%) | $8.89 M(-4.3%) |
| Sep 2017 | - | $9.29 M(-21.8%) |
| Jun 2017 | - | $11.88 M(+42.3%) |
| Mar 2017 | - | $8.35 M(+55.6%) |
| Dec 2016 | $5.36 M(+82.3%) | $5.36 M(-18.9%) |
| Sep 2016 | - | $6.62 M(-4.9%) |
| Jun 2016 | - | $6.95 M(+15.7%) |
| Mar 2016 | - | $6.01 M(+104.4%) |
| Dec 2015 | $2.94 M(-39.4%) | $2.94 M(-33.5%) |
| Sep 2015 | - | $4.42 M(-56.5%) |
| Jun 2015 | - | $10.17 M(+76.7%) |
| Mar 2015 | - | $5.75 M(+18.5%) |
| Dec 2014 | $4.86 M(+238.0%) | $4.86 M(+16.7%) |
| Sep 2014 | - | $4.16 M(+15.9%) |
| Jun 2014 | - | $3.59 M(+2.7%) |
| Mar 2014 | - | $3.50 M(+143.2%) |
| Dec 2013 | $1.44 M(+19.8%) | $1.44 M(-50.3%) |
| Sep 2013 | - | $2.89 M(+140.8%) |
| Dec 2012 | $1.20 M(+250.9%) | $1.20 M |
| Dec 2011 | $342.00 K | - |
FAQ
- What is Ultragenyx Pharmaceutical annual accounts payable?
- What is the all time high annual accounts payable for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual accounts payable year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly accounts payable?
- What is the all time high quarterly accounts payable for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly accounts payable year-on-year change?
What is Ultragenyx Pharmaceutical annual accounts payable?
The current annual accounts payable of RARE is $42.11 M
What is the all time high annual accounts payable for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual accounts payable is $43.27 M
What is Ultragenyx Pharmaceutical annual accounts payable year-on-year change?
Over the past year, RARE annual accounts payable has changed by -$1.16 M (-2.68%)
What is Ultragenyx Pharmaceutical quarterly accounts payable?
The current quarterly accounts payable of RARE is $35.99 M
What is the all time high quarterly accounts payable for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly accounts payable is $59.81 M
What is Ultragenyx Pharmaceutical quarterly accounts payable year-on-year change?
Over the past year, RARE quarterly accounts payable has changed by +$2.63 M (+7.89%)